SCHEMBL3221500

SCHEMBL3221500

CCN(CC)c1ccc(C=O)c(OCC=C(C)C)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
BACE1 P56817 4/20 0.61
ALDH3A1 P30838 1/20 0.41
ALDH1A3 P47895 1/20 0.41
RXRA P19793 1/20 0.41
MAPT P10636 6/20 0.41
KDM4E B2RXH2 5/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
HPGD P15428 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TRPA1 O75762 1/20 0.40
MTNR1A P48039 1/20 0.40
CA9 Q16790 2/20 0.38
GAA P10253 1/20 0.38
LMNA P02545 3/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3208275 0.84 BACE1 (0.84) ALDH1A1L3MBTL1BACE1RXRAMAPT
SCHEMBL3208287 0.84 BACE1 (0.84) ALDH1A1L3MBTL1BACE1RXRAMAPT
SCHEMBL28370301 0.83 ALDH1A1 (0.67) ALDH1A1L3MBTL1BACE1ALDH3A1ALDH1A3
SCHEMBL5146907 0.83 ALDH1A1 (0.74) ALDH1A1L3MBTL1BACE1ALDH3A1ALDH1A3
SCHEMBL11864011 0.81 ALDH1A1 (0.63) ALDH1A1L3MBTL1BACE1ALDH3A1ALDH1A3
SCHEMBL3224984 0.81 ALDH1A1 (0.67) ALDH1A1L3MBTL1BACE1ALDH3A1ALDH1A3
SCHEMBL9361815 0.80 ALDH1A1 (0.70) ALDH1A1L3MBTL1BACE1ALDH3A1ALDH1A3
SCHEMBL14712980 0.80 ALDH1A1 (0.70) ALDH1A1L3MBTL1BACE1ALDH3A1ALDH1A3
SCHEMBL11420383 0.79 ALDH1A1 (0.60) ALDH1A1L3MBTL1BACE1ALDH3A1ALDH1A3
SCHEMBL7037114 0.79 ALDH1A1 (0.68) ALDH1A1L3MBTL1BACE1ALDH3A1ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 ALDH1A1 253/4885L3MBTL1 2164/4885BACE1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.